Cancer Flashcards

1
Q

Cancer classification

A

depends on :
* the site of origin
* Stage (T1-T4, N0-N1, M0-M1)
T4, N1, M1 need systemic treatment
Tumor grading ((differentiation), G1-G3)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cancer origin

A

Carcinogen – a cancer-inducing agent
Genetic changes that cause cancer:
- errors that occur as cells divide.
- damage to DNA caused by harmful substances in the environment, such as the chemicals in
tobacco smoke and ultraviolet rays from the sun
- they were inherited from our parents.
- Viruses

Examples

  • Soot –suggested to be the cause of scrotum cancer in chimney sweeps
  • Benzene – a colourless liquid, that rapidly evaporates (carcinogenic,
    causes leukemia);
  • Asbestos - a group of six different naturally occurring fibrous minerals
    that can be separated into long fibers (lung cancer)
  • Radon - a colorless and odorless radioactive gas (lung cancer)

1895 – exposure to x-rays can include tissues damage and lead to the
development of cancer
1910 – submicroscopic agent isolated from a chicken tumor can induce new
tumors in healthy chickens (Roussarcoma virus)
1927 – Herman Muller notice that X-ray of fruit flies resulted in mutant offspring

Microbial Mechanisms can aid both Oncogenesis and Tumor Suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cancer drivers

A

mutations in
proto-oncogenes, tumor suppressor genes, and DNA repair genes

Mechanism of proto-oncogene activation to oncogene in cancer:
1. translocation
2. gene amplification
3. point mutation within control element
result in more protein
4.point muttion within gene
may result in more active or degradation resistant protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Hallmarks of cancer

A

Original Hallmarks:
1.sustained proliferative signaling
2.Evading growth suppressors
3.Enabling replicative imortality
4. Activationg invasion and metastasis
5. inducing angiogenesis
6. Resisting cell death

Emerging hallmarks :
1.Avoiding immune distraction
2.Deregulating cellular energetics

Enabling factors
1. Genome instability and mutation
2. Tumor promoting inflamation

Other factors:
1. Polymorphic microbioms
2. Senescent cells
3. Unlocking phenotypic plasticity
4. Non mutational epigenetic programing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Signalling pathways in cancer

A
  • Cell cycle
  • P53 pathway (tumor suppressor pathway)
  • Myc ( MYC is a hallmark molecular feature of both the initiation and maintenance of tumorigenesis)
  • PI3K pathway (cancer cell growth)
  • Hippo pathway On-inhibits growth , proliferation , OFF- allows growth and proliferation )
  • Notch pathway (hyperactivation has been implicated as oncogenic in several cancers)
  • Keap-Nrf2 pathway ( in oxidative stress conditions - production of antioxidants
  • Wnt pathway (cell fate determination)
  • Tgf-beta pathway (before tumor creation antiproliferative effects -after tumor creation angiogenesis, immunosupression , tumor growth )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cancer therapy

A

Biomarker Testing
* Chemotherapy
* Hormone Therapy( Tamoxifen estrogen antagonist stops proliferation )
* Hyperthermia
* Immunotherapy ( special T-cells or Immune checkpoint inhibitors)
* Photodynamic Therapy (To activate a chemical – known as a photosensitizing agent – that kills only the cancer
cells.

  • Radiation Therapy
  • Stem Cell Transplant (Once they enter your bloodstream, the stem cells travel to the bone marrow, where they take the place of the cells that were destroyed by treatment)
  • Surgery
  • Targeted Therapy ( type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. It is the foundation of precision medicine.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Types of Cancer?

A

Carcinoma – formed by epithelial cells
Adenocarcinoma
Basal cell carcinoma
Squamous cell carcinoma
Transitional cell carcinoma
Sarcoma – formed in in bone and soft tissues,
Lymphoma – begins in lymphocytes
Multiple myeloma – begins in plasma cells
Melanoma – begins in cells that become melanocytes
Brain and Spinal Cord Tumors
Neuroendocrine Tumors – begins from cells that release hormones
Carcinoid Tumors – type of endocrine tumor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What distinguish normal and cancer cells?

A

Most of cancer cells are
* insensitive to density-dependent inhibition of cell proliferation
* have reduced requirements for extracellular growth factors
* autocrine growth stimulation
* No contact inhibition
* secrete proteases that digest extracellular matrix components
* secrete growth factors that promote the formation of new blood vessels
(angiogenesis)
* Fail to differentiate normally
* failure to undergo programmed cell death contribute to tumor development

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The stages of tumor development?

A

cell with genetic mutation- hyperplasia-dysplasia- in situ cancer- invasive cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cell biologists studied the characteristics of cancer cells and found:

A

Cancer cells – abnormal cells that arise from the body’s normal tissues
All cells in the tumor must have descended from a single ancestral cell
The development of cancer – a result of series of clonal expansions from a single
ancestral cell.
A series of changes leads to tumor formation.
Cancer cells are genetically unstable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How cancer diagnosed?

A

Imaging tests used in cancer
CT scan
MRI
Nuclear scan
Bone scan
PET scan
Ultrasound
X-rays

Biopsy:
with a needle
with endoscopy
with surgery

Lab tests:
Blood chemistry test
Complete blood count (CBC)
Cytogenetic analysis
Immunophenotyping
Liquid biopsy
Sputum cytology
Tumor marker tests
Urinalysis
Urine cytology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cancer prevention?

A
  • Vaccine
  • prophylaxis against HBV infection prevents HCC
  • Anti-ER ( estrogen receptor ) to prevent breast cancer
  • COX2 inhibitors, aspirin (colorectal cancer)
  • Selenium, vitamin D (no clear evidence: melanoma, lung cancer)
  • triple therapy to prevent gastric cancer (H.pylori antibiotics+proton
    pump inhibitors); antioxidants (Vitamins C and E, selenium, β-
    carotene); NSAID
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is triple negative breast cancer ?

A

Triple negative because it lack 3 imporant genes = progesterone , HER2 , estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hallmarks of cancer cell metabolism

A
  • Deregulate uptake of glucose (ATP without O2 usage) and amino acids
  • Use of central carbon metabolism to support biosynthesis
  • Use of opportunistic modes of nutrient acquisition (autophagy, micropinocytosis,
    endocytosis, entosis)
  • Expanded need of electron acceptors
  • Elevated reliance on oxidative stress protection mechanisms
  • Increase demand for nitrogen
  • Heterogeneity of metabolic adaptations
  • Metabolic interactions with the tumor microenvironment ( mire angigenesis ,other cells become protumeric, more stiffness, reduced activation of T-cells)
  • Integration into the whole-body metabolic economy ( they get inputs like glucose and GF and then secrete messages to the whole body for proteolysis, lipolysin ans insulin resistance )
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the Adaptive utility of the Warburg effect

A
  • Cells generate faster ATP than does the TCA cycle
  • Acidification of the extracellular milieu
  • Conversion of pyruvate to lactate helps to alleviate the electron load
    by directly generating NAD+ for NADH
  • Increase the capacity to generate glycolytic intermediates to support
    biomass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does IDH mutation do in cancer?

A

no demethilation of some DNA and histones

17
Q

what happens in the senescence phase?

A
  • Cellular senescence is a natural barrier to tumorigenesis; senescent cells are
    widely detected in premalignant lesions from patients with cancer.
  • Cellular senescence is induced by anticancer therapy and can contribute to some
    treatment-related adverse events (TRAEs).
  • Senescent cells exert both protumorigenic and antitumorigenic effects via cellautonomous
    and paracrine mechanisms.
  • Pharmacological modulation of senescence-associated phenotypes has the
    potential to improve therapy efficacy and reduce the incidence of TRAEs
18
Q

Role of oncogene-induced senescence in tumour suppression?

A

oncogene increases senescence , imune cells act more and secondary cell death increases

19
Q

Roles of cellular senescence in tumour promotion?

A

Can cause all the bad things
like immune avoidance , metastasis , stemness, angiogenesis

20
Q

Senolytic and senomorphic therapies in cancer?

A

make more cells senescent and and kill senescent cells

21
Q

changes in tumor microenvironment can cause :

A

fifbroblast recruitment, immune evasion ,
epithelial to mesenchimal transition ( migration ) , Angiogenesis, drugs cant reach their target, O2 can not reach there

22
Q

Common tumors from metastasis ?

A

brain( from breast, prostate ) , bone ( from colon , breast, prostate) , liver( from colon , breast, prostate,pancreas) , lungs ( from colon , breast, prostate,pancreas)

23
Q
A